Concepedia

Genliang Lu

GL

Statistics

Publications

18

Citations

1.3K

H-Index

17

Active since

2004

Affiliations

Wave Life Sciences (United States)(Current)

University of Kansas

Texas A&M University

Genliang Lu is an author at Wave Life Sciences (United States) specializing in molecular pharmacology, pharmacy, and molecular biology.

Publications per year

2004–2024

18

Publications

18

Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides

Naoki Iwamoto, David C. Butler, Nenad Svrzikapa et al. · Nature Biotechnology · 2017 · 373 citations

, , +14

<sup>99m</sup>Tc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

Shawn Hillier, Kevin Maresca, Genliang Lu et al. · Journal of Nuclear Medicine · 2013 · 224 citations · Full text

, , +17

Endogenous ADAR-mediated RNA editing in non-human primates using stereopure chemically modified oligonucleotides

Prashant Monian, Chikdu Shivalila, Genliang Lu et al. · Nature Biotechnology · 2022 · 114 citations

, , +13

Synthesis and SAR of 99mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates

Genliang Lu, Kevin Maresca, Shawn Hillier et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 93 citations

, , +12

Novel Polar Single Amino Acid Chelates for Technetium-99m Tricarbonyl-Based Radiopharmaceuticals with Enhanced Renal Clearance: Application to Octreotide

Kevin Maresca, John C. Marquis, Shawn Hillier et al. · Bioconjugate Chemistry · 2010 · 66 citations

, , +17

1–5 of 18